h The European Union has not enacted new legislation at AstraZeneca (AZN.L) The vaccine will continue in June after their work ends, European Market Commissioner Thierry Breton said on Sunday.
Breton also said he expects EU funding to be released soon on Pfizer-BioNTech (PFE.N) The vaccine may be higher than the older varieties.
The commission last month filed a lawsuit against AstraZeneca for failing to honor its COVID-19 vaccine agreement and for not having a “reliable” method of ensuring proper reproduction. read more
“We haven’t revised the law after June. We’ll see what happens,” Breton said, adding that it was a “very good vaccine.”
Concerns have been raised about the negative effects of the Anglo-Sweden vaccine COVID-19.
A European health watchdog said on Friday it was reviewing reports of complications that narrowed the arteries in those who received the shot, a move that comes after finding that the vaccine could lead to more blood-curdling cases. read more
Mr Breton said an increase in the cost of second-generation vaccines could be justified by additional research that may be needed as well as changes in industrial equipment.
The European Union has signed a new agreement with Pfizer-Biontech to receive the 1.8 billion COVID-19 vaccine for 2021-2023, to cover the shooting, donations and resale, the European Commission said on Friday. read more
“There may be a slight increase in cost but I will allow the appropriate authorities to disclose it in due course,” he told France Inter radio.
Our standards: Notes of Thomson Reuters Trust.
Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of knews.uk and knews.uk does not assume any responsibility or liability for the same.